Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.40 | N/A | +19.40% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.40 | N/A | +19.40% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed confidence in the company's product demand despite supply chain issues. They emphasized the importance of innovation for future growth.
Management highlighted strong demand for vascular products.
They noted ongoing challenges in the supply chain but remain focused on growth.
Future investments in technology were discussed as a priority.
Lemaitre Vascular's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted slightly negatively, down 0.22%, likely due to the lack of revenue data and guidance. Investors may be cautious given ongoing supply chain challenges, despite management's optimistic outlook on demand and innovation.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CADENCE DESIGN SYS I